Biopharmaceutical company
Implementation of the new health care reform law -- PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage in the essential benefit pkg., and other matters. S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014
H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY '15 through 2033
In all of the above the specific issues included potential medicare offsets that might be applied to prescription drugs, especially changes to ASP, physician payment and oncology matters S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014
H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033
In all of the above the specific issues include potential Medicare offsets that might be applied to prescription drugs HR 1919 Safeguarding America's Pharmaceutical Act of 2013 and the Senate "track and trace" legislation
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SLC HEALTH STRATEGIES, LLC
9710 Traville Gateway Drive, Number 157, Rockville, MD, 20850, US
SHARON COHEN SHARON COHEN SHARON COHEN SHARON COHEN